Image
![none](/sites/default/files/styles/100_10_4_xmedium_1x/public/2023-06/tablets-3532308_1280.jpg?h=4d70cb2a&itok=SS6QOc9b)
Photo: Leopictures
Consequently, we are rapidly running out of treatment options for resistant infections. Development of new lead compounds is a difficult, high-risk problem that requires a multidisciplinary approach.
In collaboration with health care and industry CARe works to identify new treatment options and to develop new antibiotic substances.